TerrAscend Corp. logo TSNDF - TerrAscend Corp.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY 0
BUY 1
HOLD 2
SELL 0
STRONG
SELL 0
| PRICE TARGET: $2.93 DETAILS
HIGH: $3.00
LOW: $2.85
MEDIAN: $2.92
CONSENSUS: $2.93
UPSIDE: 350.77%

Stock News

TerrAscend Reports First Quarter 2026 Financial Results

TerrAscend Reports First Quarter 2026 Financial Results

Net Revenue of $65.5 million and Gross Profit Margin of 52.8% for Q1 2026 Q1 2026 Net Cash Provided from Continuing Operations of $8.7 million, representing 13.3% Operating Cash Flow Yield 1 Q1 2026 Free Cash Flow1 of $7.8 million, representing 10.3% Free Cash Flow Yield 1 15th Consecutive Quarter of Positive Cash Flow from Continuing Operations and 11th Consecutive Quarter of Positive Free Cash Flow1 TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today reported its financial results for the first quarter ended March 31, 2026. All amounts are expressed in U.S. dollars and are prepared under U.S. Generally Accepted Accounting Principles (GAAP), unless indicated otherwise.

May 07, 2026 03:10 AM • globenewswire.com
TerrAscend (OTCMKTS:TSNDF) and Phibro Animal Health (NASDAQ:PAHC) Head to Head Analysis

TerrAscend (OTCMKTS:TSNDF) and Phibro Animal Health (NASDAQ:PAHC) Head to Head Analysis

Phibro Animal Health (NASDAQ: PAHC - Get Free Report) and TerrAscend (OTCMKTS:TSNDF - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership. Earnings and Valuation This table compares Phibro Animal

Mar 24, 2026 09:10 PM • defenseworld.net
TerrAscend Reports Fourth Quarter and Full Year 2025 Financial Results

TerrAscend Reports Fourth Quarter and Full Year 2025 Financial Results

Net Revenue of $66.1 million for Q4 2025 and $260.6 Million for FY 2025  Gross Profit Margin of 52.1% for Q4 2025 and 52.3% for FY 2025 from continuing operations Q4 2025 Net Cash provided from continuing operations of $8.3 million and Free Cash Flow¹ of $6.6 million 14 th consecutive quarter of positive Cash Flow from continuing operations and 10 th consecutive quarter of positive Free Cash Flow¹ FY 2025 Net Cash provided from continuing operations of $33.9 million and Free Cash Flow¹ of $25.3 million TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today reported its financial results for the fourth quarter and full year ended December 31, 2025. All amounts are expressed in U.S. dollars and are prepared under U.S. Generally Accepted Accounting Principles (GAAP), unless indicated otherwise.

Mar 12, 2026 12:10 PM • globenewswire.com

Price Targets